Mirae is one of the very few houses I like based on their investment process.
The investment team publishes a note titled "Indian Pharmaceuticals: Bouncing Back" (source) which makes for an interesting read in brief.
The snapshots with my markings are shared as below
Posts
No comments:
Post a Comment